Tag: 2016

  • Amanda Solloway – 2016 Parliamentary Question to the Department of Health

    Amanda Solloway – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Amanda Solloway on 2016-10-07.

    To ask the Secretary of State for Health, what proportion of the additional £1.25 billion made available in the March 2015 Budget for child and adolescent mental health services has been spent in Derby North constituency.

    Nicola Blackwood

    This information is not available in the format requested.

    We are advised by NHS England that from this additional funding the amount allocated to Southern Derbyshire Clinical Commissioning Group in 2015/16 was £1.029 million and for 2016/17 the amount is £1.370 million.

    This Government has made £1.4 billion funding available over the course of the Parliament for spending on children and young people’s mental health, with total investment to date of £453 million.

    Investment in 2015/16 included:

    – £75 million to transform local services through delivery of Local Transformation Plans (LTPs);

    – £30 million to improve community based eating disorder services; and

    – £68 million to fund expansion of the Children and Young People’s Improving Access to Psychological Therapies Programme (CYP IAPT); improvements to perinatal mental health care; investment in inpatient services for children and young people; increased workforce capability; and innovation and development of online support.

    Investment for 2016/17 includes:

    – £119 million for LTPs;

    – £30 million to improve community based eating disorder services; and

    – £131 million for workforce and system development to support LTPs; a proportion of this will be allocated to commissioners for CYP IAPT and perinatal mental healthcare.

  • Lord Alton of Liverpool – 2016 Parliamentary Question to the Department of Health

    Lord Alton of Liverpool – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-01-26.

    To ask Her Majesty’s Government what are the proposed protocols for (1) detection of aneuploidy in embryos following application of the proposed Augment technique, and (2) demonstrating that injected mitochondria either disperse so as to be equally inherited by each blastomere of any resulting embryos or are concentrated in the inner cell mass, in the recent application received by the Human Fertilisation and Embryology Authority (HFEA) for a pilot trial in the UK; what estimate the HFEA has been provided regarding (1) the likely financial costs to patients undergoing the proposed Augment procedure, and (2) the potential impact on clinical pregnancy rates of any assessments deemed to be scientifically necessary; and what assessment the HFEA has made of the ruling by the US Food and Drugs Administration in 2013 that Augment is a novel drug in need of extensive and expensive safety testing.

    Lord Prior of Brampton

    The Human Fertilisation and Embryology Authority (HFEA) advises that it does not hold data from clinics on the incidence of aneuploidy in oocytes over time, nor has it received evidence from OvaScience, Professor Simon Fishel or other sources that mitochondrial defects are primarily responsible for age-related increases in oocyte chromosomal aneuploidy.

    The HFEA also advises that it has not been made aware of any published randomised trials regarding the Augment technique and has not made an assessment of the credibility of claims by OvaScience and those previously made by Clonaid, in the light of data available in peer-reviewed journals. It is currently considering whether techniques, which involve addition of autologous mitochondria to eggs, would be legal in the United Kingdom (under the framework of the Human Fertilisation and Embryology Act 1990, as amended). Part of this consideration involves considering the claims made for Augment by Ovascience.

    The HFEA has not received any formal applications for clinical use of the Augment technique, and has not made an assessment of the ruling by the US Food and Drugs Administration to which the Noble Lord refers.

  • Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department for Education

    Lord Hunt of Kings Heath – 2016 Parliamentary Question to the Department for Education

    The below Parliamentary question was asked by Lord Hunt of Kings Heath on 2016-02-23.

    To ask Her Majesty’s Government what percentage of objections submitted to the Office of the Schools Adjudicator about the admission arrangements of schools were submitted by (1) groups and organisations, and (2) local parents, in each of the years from 2012 to 2015 inclusive.

    Lord Nash

    There is currently no requirement for an objector to identify themselves, or whether they belong to, or represent, a campaign group or organisation. Some objectors volunteer this information. However, some wish to remain anonymous and other parent objectors may not reveal whether they submitted the objection on behalf of a campaign group. We have no means of identifying this.

  • Tom Elliott – 2016 Parliamentary Question to the Department for Communities and Local Government

    Tom Elliott – 2016 Parliamentary Question to the Department for Communities and Local Government

    The below Parliamentary question was asked by Tom Elliott on 2016-03-10.

    To ask the Secretary of State for Communities and Local Government, what discussions he had with the Northern Ireland Executive on the Government’s recent application to the EU Solidarity Fund to help flood affected areas.

    James Wharton

    The Government submitted an initial UK application to the EU Solidarity Fund on Friday 26 February and we continue to refine our cost estimations.

    At the date the application was made, the Government had not been approached on this matter by the Northern Ireland Executive.

  • David Mackintosh – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    David Mackintosh – 2016 Parliamentary Question to the Department for Culture, Media and Sport

    The below Parliamentary question was asked by David Mackintosh on 2016-04-15.

    To ask the Secretary of State for Culture, Media and Sport, what progress his Department has made in encouraging diversity in leadership positions in the culture sector.

    Mr Edward Vaizey

    In the recently published Culture White Paper we made it clear that more needs to be done to encourage diversity in leadership positions. From this year, Arts Council England will publish data on leadership looking at the diversity profile of Chief Executives, Artistic Directors and Chairs of the organisations that they fund. In December 2015, the Arts Council announced four new strategic funds for diversity, totalling £8.6 million. This included £2.1 million for the Elevate fund which has been created to develop the strength, management and governance of diverse-led organisations outside the Arts Council’s National Portfolio. A new £2.6 million Change Makers fund will fund long-term relationships between National Portfolio Organisations and aspiring arts leaders from the BME and deaf and disabled communities, providing valuable experience to individuals. Both of these funds are now open for applications.

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.

    To ask the Secretary of State for Health, with reference to the report of the Independent Cancer Taskforce entitled Achieving world-class cancer outcomes: a strategy for England 2015-2020, published in July 2015, what steps Monitor and NHS England have taken to introduce new sanctions for any provider not fully complying with electronic prescribing.

    Jane Ellison

    The independent Cancer Taskforce recommended that new sanctions should be introduced to encourage e-prescribing. A mechanism to enforce contractual sanctions for non-delivery of adult chemotherapy e-prescribing systems has been created from April 2016, which requires development of an action plan by 30 June 2016 and full implementation by 31 March 2017. For children, teenagers and young adults, providers will be required to produce a robust implementation plan by 30 September 2016 and to achieve full implementation by 30 September 2017.

  • Baroness Tonge – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Baroness Tonge – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Baroness Tonge on 2016-07-11.

    To ask Her Majesty’s Government what representations they have made to the government of Israel concerning reports of Israeli troops shooting a Palestinian with Down’s Syndrome who posed no threat to those troops.

    Baroness Anelay of St Johns

    While we have not made any representations to the Israeli authorities on this specific case, we have raised our concerns with the Israeli authorities in the past about the Israel Defence Forces’ use of live fire, urging robust and transparent investigations where appropriate.

  • Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    Nicholas Soames – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Soames on 2016-10-07.

    To ask the Secretary of State for Health, what information his Department holds in the number of people in a permanent vegetative state in the UK; and how many such people are cared for by the Brighton and Sussex University Hospitals NHS Trust.

    David Mowat

    Information on the number of people in a permanent vegetative state is not collected centrally.

    Brighton and Sussex University Hospital are currently not caring for any patients in a permanent vegetative state.

  • Lord Dholakia – 2016 Parliamentary Question to the Department of Health

    Lord Dholakia – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Dholakia on 2016-01-26.

    To ask Her Majesty’s Government how many individuals have commenced interferon-free treatment for hepatitis C within a prison or secure institution in the last 12 months.

    Lord Prior of Brampton

    NHS England collect data on the offer, uptake and outcome of testing for hepatitis C for people in prison using a system of metrics co-designed with Public Health England (PHE) called the Health & Justice Indicators of Performance (HJIPs). This dataset includes information on whether those requiring treatment were referred to specialist services but does not record details of the treatment provided.

    PHE has been working with NHS England and Operational Delivery Networks (ODNs) and others on a dataset which would allow for more detailed monitoring of treatments but these have not yet been introduced. Therefore, we do not currently have any data on the number of individuals commenced on treatment for hepatitis C within a prison or other prescribed place of detention in the last 12 months. Further, we do not have data on those former prisoners commenced on treatment in the community.

  • Lord Jones of Cheltenham – 2016 Parliamentary Question to the Department for Work and Pensions

    Lord Jones of Cheltenham – 2016 Parliamentary Question to the Department for Work and Pensions

    The below Parliamentary question was asked by Lord Jones of Cheltenham on 2016-02-23.

    To ask Her Majesty’s Government how many people living in each country of the EU are in receipt of the UK state pension which is currently uprated annually under EU regulations and reciprocal agreements, and what assessment they have made of what will happen to those pensions if the UK leaves the EU.

    Baroness Altmann

    The Government has a clear position, which has remained consistent for around 70 years: UK state pensions are payable worldwide and uprated abroad where we have a legal requirement to do so for example in the European Economic Area or countries where we have a reciprocal agreement that allows for uprating. There are no plans to change this.

    Details of the numbers of people in receipt of the state pension, and whether they live in countries where the state pension is frozen or uprated, is included at Annex A. Countries where the UK state pension is up-rated are identified by an asterisk by the name of the country.

    The Government’s view is that the UK will be stronger, safer and better off in a reformed EU. Of course there is uncertainty about how a vote to leave the EU could impact on access to pensioner benefits for UK pensioners living in other parts of Europe. These questions would need to be answered as part of the process of negotiating the UK’s exit if there is a vote to leave. We could only consider the detail of access to pensions and benefits for people in receipt of UK state pensions who are resident in Europe as part of the process for leaving the EU.